The tendency of endomorphs to store fat easily can be partly attributed to metabolic problems that are genetically transmitted. For example, endomorphs often metabolize carbohydrates inefficiently. Endomorphs produce too much insulin when they eat carbohydrates and this leads to increased fat storage and difficulty in losing existing fat. Scientists claim that obesity may also be due to chemical imbalances in the brain. When injected in mice, the researchers documented a 30 percent greater weight loss because the drug caused the mice to eat less.
More research is planned to develop a similar appetite suppressing drug for humans.
Unlike Xenical, which blocks fat absorption in the intestine, this new drug would affect the brain's chemistry so that people feel full sooner. Many physicians and health professionals consider these metabolic and chemical conditions as diseases. More than 45 companies worldwide are trying to develop new obesity drugs, such as C75 because it is potentially the biggest market in the world for drug sales. According to Justin Gillis, a staff writer for the Washington Post, the stakes couldn't be higher. Before you buy into this media manipulation and run to your doctor for a prescription of latest miracle drug, you'd better wonder whether its your best interests they have in mind or the commercial interests of the pharmaceutical companies.